Alteration of the oral and gut microbiota in patients with Kawasaki disease

Background Kawasaki disease (KD) is a multi-systemic vasculitis that primarily affects children and has an unknown cause. Although an increasing number of studies linking the gut microbiota with KD, the unchallengeable etiology of KD is not available. Methods Here, we obtained fecal and oral samples from KD patients and healthy controls, and then we use high-throughput sequencing to examine the diversity and composition of microbiota. Results Results showed that both in the gut and oral microbiota, the diversity of KD patients was significantly lower than that of the healthy controls. In the gut microbiota, a higher abundance of Enterococcus (40.12% vs less than 0.1%), Bifidobacterium (20.71% vs 3.06%), Escherichia-Shigella (17.56% vs 0.61%), Streptococcus (5.97% vs 0.11%) and Blautia (4.69% vs 0.1%) was observed in the KD patients, and enrichment of Enterococcus in the patients was observed. In terms of oral microbiota, the prevalence of Streptococcus (21.99% vs 0.1%), Rothia (3.02% vs 0.1%), and Escherichia-Shigella (0.68% vs 0.0%) were significantly higher in the KD patients, with the enrichment of Streptococcus and Escherichia-Shigella. Additionally, significant differences in microbial community function between KD patients and healthy controls in the fecal samples were also observed, which will affect the colonization and reproduction of gut microbiota. Conclusions These results suggested that the dysbiosis of gut and oral microbiota are both related to KD pathogenesis, of which, the prevalence of Enterococcus in the gut and higher abundance of Streptococcus and Escherichia-Shigella in the oral cavity will be a potential biomarker of the KD. Overall, this study not only confirms that the disturbance of gut microbiota is a causative trigger of KD but also provides new insight into the oral microbiota involved in KD pathogenesis.

[1]  Xuedong Zhou,et al.  Oral microbiota in human systematic diseases , 2022, International journal of oral science.

[2]  Yue Liu,et al.  Oral, Tongue-Coating Microbiota, and Metabolic Disorders: A Novel Area of Interactive Research , 2021, Frontiers in Cardiovascular Medicine.

[3]  M. Curtis,et al.  The role of oral bacteria in inflammatory bowel disease , 2021, Nature Reviews Gastroenterology & Hepatology.

[4]  G. Lafaurie,et al.  Porphyromonas gingivalis Placental Atopobiosis and Inflammatory Responses in Women With Adverse Pregnancy Outcomes , 2020, Frontiers in Microbiology.

[5]  H. Tuominen,et al.  Oral Microbiota and Cancer Development , 2020, Pathobiology.

[6]  Chaochao Tan,et al.  Altered gut microbiota correlated with systemic inflammation in children with Kawasaki disease , 2020, Scientific Reports.

[7]  Mingyi Zhao,et al.  Effects of changes on gut microbiota in children with acute Kawasaki disease , 2020, PeerJ.

[8]  K. Kaneko,et al.  Our Evolving Understanding of Kawasaki Disease Pathogenesis: Role of the Gut Microbiota , 2020, Frontiers in Immunology.

[9]  B. Law,et al.  Correlation of gut microbial compositions to the development of Kawasaki disease vasculitis in children. , 2020, Future microbiology.

[10]  A. Moreira Kawasaki disease linked to COVID-19 in children , 2020, Nature Reviews Immunology.

[11]  Angelo Mazza,et al.  An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study , 2020, The Lancet.

[12]  Russell M Viner,et al.  Kawasaki-like disease: emerging complication during the COVID-19 pandemic , 2020, The Lancet.

[13]  A. Kengne,et al.  Oral Microbiome Signatures in Diabetes Mellitus and Periodontal Disease , 2020, Journal of dental research.

[14]  S. Esposito,et al.  The Gut Microbiota-Host Partnership as a Potential Driver of Kawasaki Syndrome , 2019, Front. Pediatr..

[15]  P. Bullón,et al.  A review of the influence of periodontal treatment in systemic diseases , 2019, Periodontology 2000.

[16]  Y. Date,et al.  Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome , 2018, mSphere.

[17]  P. Xian,et al.  The Oral Microbiome Bank of China , 2018, International Journal of Oral Science.

[18]  Feng Chen,et al.  Oral microbiomes: more and more importance in oral cavity and whole body , 2018, Protein & Cell.

[19]  Jia Gu,et al.  fastp: an ultra-fast all-in-one FASTQ preprocessor , 2018, bioRxiv.

[20]  B. McCrindle,et al.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.

[21]  M. Kuroda,et al.  Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis , 2015, Front. Microbiol..

[22]  G. Ruoppolo,et al.  Kawasaki disease: an evolving paradigm. , 2015, Autoimmunity reviews.

[23]  H. Takada,et al.  Kawasaki Disease-Specific Molecules in the Sera Are Linked to Microbe-Associated Molecular Patterns in the Biofilms , 2014, PloS one.

[24]  Julie K. Pfeiffer,et al.  Viruses and the Microbiota. , 2014, Annual review of virology.

[25]  Robert C. Edgar,et al.  UPARSE: highly accurate OTU sequences from microbial amplicon reads , 2013, Nature Methods.

[26]  S. Esposito,et al.  The role of infection in Kawasaki syndrome , 2013, Journal of Infection.

[27]  S. Dominguez,et al.  Kawasaki Disease and the Pediatric Gastroenterologist: A Diagnostic Challenge , 2013, Journal of pediatric gastroenterology and nutrition.

[28]  Yusuke Nakamura,et al.  A genome-wide association study identifies three new risk loci for Kawasaki disease , 2012, Nature Genetics.

[29]  R. Uehara,et al.  Epidemiology of Kawasaki Disease in Asia, Europe, and the United States , 2012, Journal of epidemiology.

[30]  Yoshiya Tanaka,et al.  Evaluation of intestinal microbiotas of healthy Japanese adults and effect of antibiotics using the 16S ribosomal RNA gene based clone library method. , 2011, Biological & pharmaceutical bulletin.

[31]  B. Kampmann,et al.  Kawasaki disease coincident with influenza A H1N1/09 infection , 2011, Pediatrics international : official journal of the Japan Pediatric Society.

[32]  Y. Zu,et al.  The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease , 2010, Clinical and experimental immunology.

[33]  L. Hancock,et al.  Enterococcal Biofilm Formation and Virulence in an Optimized Murine Model of Foreign Body-Associated Urinary Tract Infections , 2010, Infection and Immunity.

[34]  Teruyo Ito,et al.  Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease , 2009, Immunology.

[35]  Martin Hartmann,et al.  Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities , 2009, Applied and Environmental Microbiology.

[36]  Anbupalam Thalamuthu,et al.  A Genome-Wide Association Study Identifies Novel and Functionally Related Susceptibility Loci for Kawasaki Disease , 2009, PLoS genetics.

[37]  R. Uehara,et al.  Monthly Observation of the Number of Patients with Kawasaki Disease and its Incidence Rates in Japan: Chronological and Geographical Observation from Nationwide Surveys , 2008, Journal of epidemiology.

[38]  Hubert Hilbi,et al.  Molecular Pathogenesis of Shigella spp.: Controlling Host Cell Signaling, Invasion, and Death by Type III Secretion , 2008, Clinical Microbiology Reviews.

[39]  J. Tiedje,et al.  Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.

[40]  A. Harnden,et al.  Kawasaki disease: What is the epidemiology telling us about the etiology? , 2005, International Journal of Infectious Diseases.

[41]  J. Warren,et al.  Emerging Incidence of Enterococcus faecium among Hospital Isolates (1993 to 2002) , 2005, Journal of Clinical Microbiology.

[42]  Walter R Wilson,et al.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association , 2004, Circulation.

[43]  I. Sekine,et al.  Characteristic Profile of Intestinal Microflora in Kawasaki Disease , 2002, Pediatric Research.

[44]  I. Sekine,et al.  Increased Levels of Lipopolysaccharide Binding Protein in Plasma in Children with Kawasaki Disease , 2002, Clinical and Vaccine Immunology.

[45]  S. Salzberg,et al.  FLASH: fast length adjustment of short reads to improve genome assemblies , 2011, Bioinform..